Freedom from Structural Valve Deterioration
Author | Year | No. of Patients |
Type of Study |
Type of Valve |
Mean Age at Implant | Mean Follow-Up (yrs) |
5 years (%) |
10 years (%) |
15 years (%) |
20 years (%) |
25 years (%) |
Linearized rate (% per pt year) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cohn et al, | 1998 | 843 | Prospective Follow-Up | Hancock modified orifice porcine | 69 | 6 | 99 | 79 | 57 | - | - | - |
Khan et al, | 1998 | 243 | Retrospective | Hancock Porcine | 68 | 7 | - | - | - | - | - | - |
Poirier et al, | 1998 | 598 | Prospective Follow-Up | *CE bovine pericardial | 65 | 4.8 | 99 | 93 | 80 (14yr) | - | - | 0.7 |
Banbury et al, | 2001 | 267 | Prospective Follow-Up | CE bovine pericardial | 65 | 12 | 99 | 94 | 77 | - | - | - |
David et al, | 2001 | 670 | Prospective Follow-Up | Hancock II porcine | 65 | 7.3 | 100 | 97 | 81 | - | - | - |
Jamieson et al, | 2006 | 1823 | Prospective Follow-Up | CE supra-annular porcine | 69 | 7.9 | - | 89 (12yr) | 75 | - | - | |
Jamieson et al, | 2006 | 1430 | Prospective Follow-Up | CE perimount pericardial | 70 | 5.4 | - | 93 (12yr) | 88 | - | - | |
Rizzoli et al, | 2006 | 809 | Prospective Follow-Up | Hancock II porcine | 68 | 12 | 100 | 97 | 85 | - | - | - |
Jamieson et al, | 2009 | 381 | Retrospective | Mitroflow pericardial | 76 | 5.4 | 99 | 86 | - | - | - | 0.8 |
Myken et al, | 2009 | 1518 | Prospective Follow-Up | St. Jude Medical Biocor | 71 | 6 | - | - | - | 61* | - | 0.9 |
David et al, | 2010 | 1134 | Prospective Follow-Up | Hancock II porcine | 67 | 12.2 | 99 | 98 | 87 | 63 | - | - |
McClure et al, | 2010 | 1000 | Prospective Follow-Up | CE bovine pericardial | 74 | 6 | 99 | 97 | 82 | - | - | - |
Riess et al, | 2010 | 255 | Prospective Follow-Up | Medtronic Mosaic porcine | 69 | 8.3 | 100 (4yr) | 100 (8yr) | 85 (13yr) | - | - | 0.5 |
ISTHMUS | 2011 | 1591 | Retrospective | Mitroflow pericardial | 75 | 5.2 | - | - | - | 66 (18yr) | - | 1.4 |
Jamieson et al, | 2011 | 797 | Prospective Follow-Up | Medtronic Mosaic porcine | 69 | 7.5 | 100** | 95** | 91 (12yr)** | - | - | - |
Aaron J. Weiss M.D., Stephen M. Spindel M.D., and Farzan Filsoufi M.D.
** Values correspond to actuarial freedom from reoperation because of structural valve deterioration (SVD). Patients that had SVD without reoperation were not detailed in this study.
- Cohn LH, Collins JJ, Jr., Rizzo RJ, et al. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg 1998;66:S30-4.
- Khan SS, Chaux A, Blanche C, et al. A 20-year experience with the Hancock porcine xenograft in the elderly. Ann Thorac Surg 1998;66:S35-9.
- Poirer NC, Pelletier LC, Pellerin M, et al. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg 1998;66:S57-61.
- Banbury MK, Cosgrove DM, 3rd, White JA, et al. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2001;72:753-7.
- David TE, Ivanov J, Armstrong S, et al. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001;121:268-77.
- Jamieson WR, Germann E, Aupart MR, et al. 15-year comparison of supra-annular porcine and PERIMOUNT aortic bioprostheses. Asian Cardiovasc Thorac Ann 2006;14:200-5.
- Rizzoli G, Mirone S, Ius P, et al. Fifteen-year results with the Hancock II valve: a multicenter experience. J Thorac Cardiovasc Surg 2006;132:602-9, 609 e1-4.
- Jamieson WR, Koerfer R, Yankah CA, et al. Mitroflow aortic pericardial bioprosthesis--clinical performance. Eur J Cardiothorac Surg 2009;36:818-24.
- Myken PS, Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg 2009;137:76-81.
- David TE, Armstrong S, Maganti M. Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Ann Thorac Surg 2010;90:775-81.
- McClure RS, Narayanasamy N, Wiegerinck E, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg 2010;89:1410-6.
- Riess FC, Cramer E, Hansen L, et al. Clinical results of the Medtronic Mosaic porcine bioprosthesis up to 13 years. Eur J Cardiothorac Surg 2010;37:145-53.
- Investigators I. The Italian study on the Mitroflow postoperative results (ISTHMUS): a 20-year, multicentre evaluation of Mitroflow pericardial bioprosthesis. Eur J Cardiothorac Surg 2011;39:18-26; discussion 26.
- Jamieson WR, Riess FC, Raudkivi PJ, et al. Medtronic Mosaic porcine bioprosthesis: assessment of 12-year performance. J Thorac Cardiovasc Surg 2011;142:302-7 e2.